Alzheimer’s disease: Insights for risk evaluation and prevention in the Chinese population and the need for a comprehensive programme in Hong Kong/China

21Citations
Citations of this article
113Readers
Mendeley users who have this article in their library.

Abstract

With the ageing of the global population, China is projected to be impacted significantly by the rising number of patients with Alzheimer’s disease (AD). A cure for AD is not yet available, so society should be prepared for an increasing AD-related burden. In this review, we examine this impending problem and provide overviews on (a) the magnitude of the problem of AD in Hong Kong/China in the near future; (b) the genetic and lifestyle risk factors that contribute to AD; (c) current diagnostic approaches and the potential of newly discovered genetic biomarkers for early detection; (d) medications, non-pharmacological interventions, and possible preventive measures; and (e) the need for social and psychological care from the community. In Hong Kong, primary care and AD-related support for at-risk individuals, patients, and caregivers are inadequate. A joint effort from the medical community, government, universities, non-governmental organisations/charities, and industry should initiate the development of a long-term programme for AD. Finally, we outline recommendations for the relevant. parties to consider.

Cite

CITATION STYLE

APA

Yee, A., Tsui, N. B. Y., Chang, Y. N., Au, C. S. M., Fok, M., Lau, L. T., … Dai, D. L. K. (2018, October 1). Alzheimer’s disease: Insights for risk evaluation and prevention in the Chinese population and the need for a comprehensive programme in Hong Kong/China. Hong Kong Medical Journal. Hong Kong Academy of Medicine Press. https://doi.org/10.12809/hkmj187244

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free